SYSTEMS, METHODS, AND APPARATUSES FOR MONITORING END STAGE RENAL DISEASE
    121.
    发明申请
    SYSTEMS, METHODS, AND APPARATUSES FOR MONITORING END STAGE RENAL DISEASE 有权
    用于监测终末期肾病的系统,方法和装置

    公开(公告)号:US20130303865A1

    公开(公告)日:2013-11-14

    申请号:US13892166

    申请日:2013-05-10

    Abstract: An end stage renal disease (ESRD) monitoring system may include an implantable sensor and a reader device with an optical sensor. The implantable sensor may be configured to detect a group of analytes relevant to ESRD, such as glucose, creatinine, urea, and potassium. The implantable sensor may be implanted into the dermis of an animal, and may exhibit color changes in response to the presence of the target analytes or reaction product(s) thereof. The reader device may be configured to capture an image of the implanted sensor and to determine the concentration of the target analytes based at least in part on the image. The reader device may be a personal electronic device such as a cell phone, PDA, or personal computer.

    Abstract translation: 终末期肾病(ESRD)监测系统可以包括可植入传感器和具有光学传感器的读取装置。 可植入传感器可以被配置为检测与ESRD相关的一组分析物,例如葡萄糖,肌酐,尿素和钾。 可植入传感器可以植入动物的真皮中,并且可以响应于目标分析物或其反应产物的存在而显示颜色变化。 读取器设备可以被配置为捕获植入的传感器的图像并且至少部分地基于图像来确定目标分析物的浓度。 读取器设备可以是诸如手机,PDA或个人计算机的个人电子设备。

    Patient hydration system and method
    125.
    发明授权
    Patient hydration system and method 有权
    患者水合系统及方法

    公开(公告)号:US08007460B2

    公开(公告)日:2011-08-30

    申请号:US12800699

    申请日:2010-05-20

    Abstract: A patient hydration system including an infusion device for administering hydration fluid to a patient, and a hydration fluid measurement device responsive to a source of hydration fluid, a patient urine output measurement device. A controller is responsive to the hydration fluid measurement device and the patient urine output measurement device. The controller operates the infusion device, in response to the patient urine output measurement device and the hydration fluid measurement device, to hydrate the patient based on the patient's urine output. The controller also monitors the operation history of the infusion device thereby providing redundancy in the measurement of the amount of hydration fluid administered to the patient.

    Abstract translation: 一种患者水合系统,包括用于向患者施用水合流体的输注装置,以及响应于水合流体源的水合流体测量装置,患者尿液输出测量装置。 控制器响应于水合流体测量装置和患者尿液输出测量装置。 控制器响应于患者尿液输出测量装置和水合流体测量装置操作输液装置,以基于患者的尿液输出水合患者。 控制器还监测输注装置的操作历史,从而在测量给予患者的水合液量的量方面提供冗余。

    DEVICE FOR THE ANALYSIS OF URINE
    128.
    发明申请
    DEVICE FOR THE ANALYSIS OF URINE 有权
    尿液分析装置

    公开(公告)号:US20110092786A1

    公开(公告)日:2011-04-21

    申请号:US12736539

    申请日:2009-03-23

    CPC classification number: A61F5/453 A61B5/14507 A61B5/20 A61B5/201

    Abstract: A device for the analysis of urine designed to be connected in series to a catheter (12) of a patient's urine, comprises: —means (14) for analyzing a sample of urine, —means (13, 19) for feeding a pre-established quantity of urine coming from the catheter to said analysis means, and —automatic control means (21) for controlling the feeding of the pre-established quantity of urine to the analysis means through said means for feeding, and for activating the analysis of the urine through said urine analysis means when the pre-established quantity of urine is supplied thereto.

    Abstract translation: 一种用于分析设计成与患者尿液的导管(12)串联连接的尿液的装置,包括: - 用于分析尿液样本的装置(14), - 用于供给预先测定的尿液的装置(13,19) 建立从导管到所述分析装置的尿量;以及 - 自动控制装置(21),用于通过所述供给装置控制将预先确定的尿量输送到分析装置的自动控制装置(21) 通过所述尿液分析的尿液,当向尿液提供预先确定的尿量时,

    IN-VITRO DEVICE SUPPORT FOR X-RAY BASED KIDNEY FUNCTION TEST
    130.
    发明申请
    IN-VITRO DEVICE SUPPORT FOR X-RAY BASED KIDNEY FUNCTION TEST 审中-公开
    基于X-RAY的KIDNEY功能测试的体内设备支持

    公开(公告)号:US20100332254A1

    公开(公告)日:2010-12-30

    申请号:US12492329

    申请日:2009-06-26

    CPC classification number: A61B6/481 A61B5/201 A61B5/411 A61B5/7275 G06Q50/24

    Abstract: A system and method of diagnosing kidney syndromes using an intravenous pyelogram (IVP) is described. The system includes an X-ray imaging device and an in-vitro diagnostic (IVD) device. The IVD device is used to identify risk factors such as sensitivity to contrast agents, or to indicate or rule out other syndromes which may have symptoms similar to kidney malfunction. The level of blood components such as creatinine may be used, in conjunction with other medical data and IVD tests, to determine a risk score for the patient. The risk score may be used to recommend modifications to a baseline procedure such as change in the volume or type of contrast agent, the number of X-rays, or the performance of post-procedure dialysis.

    Abstract translation: 描述了使用静脉肾盂造影(IVP)诊断肾综合征的系统和方法。 该系统包括X射线成像装置和体外诊断(IVD)装置。 IVD装置用于识别对造影剂的敏感性等危险因素,或指示或排除可能具有类似于肾功能障碍的症状的其他综合征。 可以结合其他医疗数据和IVD测试来使用血液成分如肌酐的水平来确定患者的风险评分。 风险评分可用于推荐对基线程序的修改,例如造影剂的体积或类型的变化,X射线的数量或手术后透析的表现。

Patent Agency Ranking